ArticleJournal of pharmacy & bioallied sciences2025
A Comprehensive Evaluation of Rapid Diagnostic Methods in Neonatal Sepsis: Evaluating Their Accuracy, Turnaround Time, and Impact on Antibiotic Stewardship and Clinical Outcomes.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal sepsis is a leading cause of morbidity and mortality among births in newborns in the global community. The current diagnostic approaches, especially blood culture, are insensitive and take a long time to give results, thus delaying treatment and increasing dependence on empirical broader spectrum antibiotics. Challenges posed by slow pathogen detection continue to be a norm in diagnostic platforms. Innovations like polymerase chain reaction (PCR), microfluidics, and procalcitonin (PCT) present probable solutions that can enhance pathogen detection. Methodology: This prospective observational study was conducted over 6 months from February 2024 to July 2024 at the neonatal intensive care unit (NICU) of Maheshwara Medical College, Hyderabad, India. We randomized the newborns to receive rapid diagnostic methods or standard blood cultures in 200 patients with suspected sepsis. This research assessed diagnostic concordance, time to result, antibiotic prescriptions, and clinical performance indicators such as mortality, NICU length of stay, and readmission. Results: Rapid diagnostic methods significantly outperformed conventional blood cultures in diagnostic accuracy, with PCR assays showing 92% sensitivity and 89% specificity. Turnaround times for PCR, microfluidics, and PCT tests were 6, 4, and 2 h, respectively, compared to 48-72 h for blood cultures. The implementation of rapid diagnostics led to a reduction in empirical antibiotic initiation from 95% to 70%, increased antibiotic de-escalation from 20% to 50%, and shortened antibiotic therapy duration from 8 to 6 days. Clinically, mortality rates decreased from 15% to 10%, NICU stay reduced from 14 to 11 days, and readmission rates dropped from 8% to 5%. Conclusion: This is because rapid diagnostic methods enhance the diagnosis of neonatal sepsis by increasing accuracy and also shortening the duration taken in its diagnosis. This helps in the efficient use of antibiotics, and hence good clinical results were observed. Of these, some can improve care, limit the use of antibiotics, and hence prevent the development of resistance and improve management of neonatal sepsis, especially in limited resource regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.